Feature
MOTS-c: Where the Evidence Ends
Studies offer clues about ageing and metabolism. What do they actually tell us about human health—and where does expert opinion take over?
Aging Cell
In Vivo Partial Cell Reprogramming With Yamanaka Factors Reduced Ischemic Brain Damage in Aging Mice
Transient expression of a reduced Yamanaka-factor set in aged mice reduced ischemic brain damage and improved recovery.
Key takeaways
- This was an animal study and does not prove human efficacy.
- Researchers transiently applied a reduced Yamanaka-factor set in aged mice.
- Treated aged mice showed reduced ischemic brain damage versus controls.
